Evidence map›Paper›PMID 40536237›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2025

An N-Terminally Elongated Peptide From Conus rolani Defines a New Class of Ribbon α-Conotoxins Targeting Muscle nAChRs.

Matías L Giglio, Paula Flórez-Salcedo, Layla Azam, Maren Watkins, Thomas Lund Koch, Erianna Basgall-De la Rosa, Adam D Douglass, J Michael McIntosh, Baldomero M Olivera, Joanna Gajewiak

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. An N-Terminally Elongated Peptide From Conus rolani Defines a New Class of Ribbon α-Conotoxins Targeting Muscle nAChRs.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Matías L GiglioSchool of Biological Sciences, University of Utah, Salt Lake City, Utah, USA.ORCID https://orcid.org/0000-0002-6357-9772
Paula Flórez-SalcedoSchool of Biological Sciences, University of Utah, Salt Lake City, Utah, USA.ORCID https://orcid.org/0000-0002-2109-8612
Layla AzamSchool of Biological Sciences, University of Utah, Salt Lake City, Utah, USA.ORCID https://orcid.org/0009-0005-4325-5067
Maren WatkinsSchool of Biological Sciences, University of Utah, Salt Lake City, Utah, USA.ORCID https://orcid.org/0000-0002-4127-1961
Thomas Lund KochSchool of Biological Sciences, University of Utah, Salt Lake City, Utah, USA.ORCID https://orcid.org/0000-0002-8489-0375
Erianna Basgall-De la RosaDepartment of Neurobiology, University of Utah, Salt Lake City, Utah, USA.ORCID https://orcid.org/0000-0003-1794-3622
Adam D DouglassDepartment of Neurobiology, University of Utah, Salt Lake City, Utah, USA.ORCID https://orcid.org/0000-0001-7859-314X
J Michael McIntoshSchool of Biological Sciences, University of Utah, Salt Lake City, Utah, USA.ORCID https://orcid.org/0000-0001-9939-7981
Baldomero M OliveraSchool of Biological Sciences, University of Utah, Salt Lake City, Utah, USA.ORCID https://orcid.org/0000-0003-4556-1410
Joanna GajewiakSchool of Biological Sciences, University of Utah, Salt Lake City, Utah, USA.ORCID https://orcid.org/0000-0003-3608-9935

Funding

“Conus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discovery”R01GM144719 · NIGMS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI OLIVERA, BALDOMERO M, RAGHURAMAN, SHRINIVASAN · 2022 to 2025
$2.5M
Development and Application of Nicotinic Acetylcholine Receptor Targeted Peptides for Biomedical ResearchR35GM136430 · NIGMS · UNIVERSITY OF UTAH · PI MCINTOSH, J MICHAEL · 2020 to 2024
$2.3M
Cellular and circuit mechanisms enabling oxytocinergic control of pain defenseR01NS111067 · NINDS · UNIVERSITY OF UTAH · PI DOUGLASS, ADAM D · 2019 to 2023
$1.7M
HHS | NIH | National Institute of General Medical Sciences (NIGMS) RO1 GM144719HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) RO1 NS111067NIGMS NIH HHS R01 GM144719NIGMS NIH HHS R35 GM136430NINDS NIH HHS R01 NS111067
6 · The paper itself

Abstract

Conotoxins, peptides found in cone snail venoms, selectively target ion channels and receptors to incapacitate prey. α-Conotoxins are extensively investigated for their potent modulation of nicotinic acetylcholine receptors (nAChRs). This study describes the discovery and characterization of RoIA, a novel α-conotoxin from Conus rolani. RoIA belongs to the α4/4 conotoxin class and features an atypical N-terminal elongation of 18 amino acids. The biological activity of RoIA is assessed through both in vivo and in vitro assays using the three potential folding isoforms (globular, ribbon, and bead) of the full-length and truncated (lacking the N-terminal elongation) analogs. The full-length RoIA analog exhibits delayed but potent paralytic activity when administered to mice and fish; the ribbon isoform shows the highest potency. Notably, only the ribbon isoform of the truncated peptide is active on heterologously expressed muscle nAChRs, suggesting that the N-terminal elongation may be released in vivo or form interactions that are not recapitulated in vitro. This discovery challenges the prevailing understanding that native α-conotoxins adopt a globular conformation and illustrates that Conus can explore novel chemical spaces using an alternative disulfide bond connectivity. This research enhances our knowledge of the complex mechanisms by which toxins manifest their physiological effects.

Indexed as

ConotoxinsConus SnailMusclesPeptidesReceptors, NicotinicAmino Acid SequenceAnimalsAnimals, PoisonousMiceConotoxinsPeptidesReceptors, Nicotinicbioassaydisulfide connectivityelectrophysiologynAChRpeptide stabilityvenomα‐Conotoxin

Identifiers

PMID40536237
PMCPMC12178101

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.